Intervention
ultrafiltration
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownTolvaptan/Ultrafiltration in the Treatment of Acute Heart FailureNCT01863511 · 2013-05-01
COMPLETEDThe Role of Adrenomedullin on the Outcome of Severe Heart Failure: a Clinical Randomized StudyNCT01154504 · 2010-04-01
WITHDRAWNThe Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney FunctionNCT01077895 · 2010-02-01
WITHDRAWNCardiorenal Interactions During Treatment of Acute Decompensated Heart Failure: Diuretics Versus UltrafiltrationNCT01138683 · 2010-02-01
COMPLETEDTreatment of Severe Heart Failure by UltrafiltrationNCT00360958 · 2006-08-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED3
WITHDRAWN2
Phase mix
PHASE32
PHASE42
NA1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.